Controversies in the Pandemic

SECTION 1: CONTROVERSIES
CHAPTER 1: Introduction
CHAPTER 2: The Totality of Evidence
CHAPTER 3: COVID-19 Censorship in the European Union: The Example of Austria
CHAPTER 4: COVID-19, Hydroxychloroquine, Politics, and Scientific Author Political Party Donation History—What could Possibly Go Wrong?
CHAPTER 5: “You are not a Horse”: Medicalization, Social Control, and Academic Discourse in the COVID-19 Era
CHAPTER 6: Origin of COVID Pandemic: A Natural Calamity or Manmade Adventure
CHAPTER 7: Origins of COVID through the Indian Context
CHAPTER 8: Gain-of-function and Origin of COVID-19
CHAPTER 9: The Enigma of the 1889 Russian Flu Pandemic: A Coronavirus?
 
SECTION 2: NONPHARMACOLOGIC INTERVENTIONS
CHAPTER 10: The Use of Masks in the Prevention of SARS-CoV-2 Transmission
CHAPTER 11: Managing COVID-19 in Hong Kong: Lessons from SARS 2003 and Effective Strategies for Control
CHAPTER 12: COVID-19 and Dentistry
CHAPTER 13: The Evolving Role of Simulation in Surgical Training
CHAPTER 14: The Impact of the COVID-19 Pandemic on Nursing
CHAPTER 15: Immunology in COVID-19
CHAPTER 16: The Experience in the Making of COVID-19 Vaccines
CHAPTER 17: Controversies Concerning the Immunology of the COVID-19 Adaptive Immunity Vaccines
CHAPTER 18: The COVID-19 Vaccine
 
SECTION 3: SPECIAL ISSUE OF INTEREST
CHAPTER 19: The Art of Living
CHAPTER 20: Computed Tomography Thorax in COVID Management: A Rightfully Used or Misused Tool?
CHAPTER 21: Surgical Education and Training during the COVID-19 Pandemic
 
SECTION 4: THERAPIES
CHAPTER 22: The Need to Revisit Hydroxychloroquine in Early Treatment Strategies of COVID-19
CHAPTER 23: Ivermectin
CHAPTER 24: Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
CHAPTER 25: Antivirals
CHAPTER 26: Glucocorticoids in Viral Pneumonia and COVID-19
CHAPTER 27: Therapeutic Effects of Fluvoxamine in the Management of COVID-19
CHAPTER 28: Randomized Placebo Controlled Trials in the COVID Era: A Question of Faith?
 
SECTION 5: COMPLICATIONS
CHAPTER 29: An Update on the Relationship between SARS-CoV-2 (COVID-19) and its Neurological Manifestations
CHAPTER 30: Myocarditis: COVID-19 and COVID-19 Vaccines
CHAPTER 31: Injuries from the SARS CoV-2 Vaccines
CHAPTER 32: Tracheostomy during COVID-19 Pandemic; To Do or Not To Do
CHAPTER 33: Telemedicine for Medical Students—Lessons Learnt from the Pandemic
CHAPTER 34: Censorship of the Biomedical Literature during the COVID-19 Era

Joseph Varon MD FACP FCCP FCCM FRSM
Professor, The University of Houston College of Medicine, Houston, Texas, USA
Paul E Marik MD MBBS
Chief Medical Officer, Front Line Critical Care Consortium, FLCCC Alliance, Washington DC, USA
Marc Rendell MD
Medical Director, The Rose Salter Medical Research Foundation, Newport Coast, California, USA
Jose Iglesias DO FASN
Department of Medicine, Rutgers Health/Community Medical Centre, Internal Medicine Residency Program, Community Medical Centre, RWJBH, Toms River, New Jersey, USA
Christopher de Souza DORL MS DNB FACS (USA) FRCS (England) FRCS (Ireland) Fellow of the American Neurotology Society Doctor of Literature (Honoris Causa)
Maharashtra University of Health Sciences, Nashik, Maharashtra, India
Prahlad Prabhudesai MBBS MD DNB FCCP
Consultant in Pulmonary Medicine, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India